Preemptive transplant is the best option for the vast majority of patients with ESKD; however, innovation is needed to keep up with the demand for kidneys. Listen to this podcast, in which Allen Nissenson, MD, chief medical officer of DaVita and emeritus professor of Medicine at UCLA along with Gabriel Danovitch, MD, medical director of the Kidney Transplant Program and professor of medicine at UCLA discuss the current state of kidney transplantation and how that state can be improved through innovation. Drs. Nissenson and Danovitch also describe how nephrologists and providers can help patients be transplant ready through education and waitlist support. Finally, they discuss current developments in transplantation that may help the transplanted kidneys function better in the future, as well as the need for innovations in kidney disease prevention.